5th Nov 2014 09:50
LONDON (Alliance News) - PuriCore PLC on Wednesday said it has won two patents in the US which will strengthen its product portfolio and its pipeline.
The first patent will cover the stabilisation of hypochlorous acid, particularly at high concentrations, in a variety of product formulations. The second covers the use of PuriCore's hypochlorous acid formulation for the prevention and treatment of conditions characterised by infection and/or inflammation, the company said.
"The grant of these patents provides a key competitive advantage for the company, particularly as we look to expand our bottled, consumable products and as we develop new products in the infection control, dermatology, and wound care arenas," said PuriCore Chief Executive Officer Michael Ashton.
PuriCore shares were boosted by the news at the open Wednesday but have since retreated to 30.50 pence, flat on the day.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
PURI.L